SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Sugg SL, Donegan WL. Staging and prognosis. In: DoneganWL, SprattJS, editors. Cancer of the breast, 5th edition. Philadelphia: Saunders, 2002: 477506.
  • 2
    Hortobagyi G, Singletary SE, Strom EA. Treatment of locally advanced and inflammatory breast cancer. In: HarrisJR, LippmanME, MorrowM, OsborneCK, editors. Diseases of the breast, 2nd edition. Philadelphia: Lippincott Williams & Wilkins, 2000: 645660.
  • 3
    Sikov WM. Locally advanced breast cancer. Curr Treat Options Oncol. 2000; 1: 228238.
  • 4
    SobinLH, WittekindC, editors. TNM classification of malignant tumors, 6th edition. New York: John Wiley & Sons, 2002.
  • 5
    Greene FL, Page D, Morrow M, et al., editors. AJCC cancer staging manual, 6th edition. New York: Springer-Verlag, 2002.
  • 6
    WittekindC, HensonDE, HutterRV, SobinLH, editors. TNM supplement. A commentary on uniform use, 2nd edition. New York: John Wiley & Sons, 2001.
  • 7
    Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,730 breast cancer cases. Cancer. 1989; 63: 181187.
  • 8
    Rubens RD, Armitage P, Winter PJ, et al. Prognoses in inoperable Stage III carcinoma of the breast. Eur J Cancer. 1977; 13: 805811.
  • 9
    Zucali R, Kenda R. Small size T4 breast cancer. Natural history and prognosis. Tumori. 1981; 67: 225230.
  • 10
    Sutherland CM, Mather FJ. Long-term survival and prognostic factors in patients with regional breast cancer (skin, muscle and/or chest wall involvement). Cancer. 1985; 55: 13891397.
  • 11
    El-Tamer M, Hussain S, Weedon J, et al. Prognoses of T4 breast cancer subsets. Ann Surg Oncol. 2002; 9: 340345.
  • 12
    Glinski B, Pawlicki M, Reinfuss M, et al. Multimodality treatment of noninflammatory Stage IIIb breast cancer. J Surg Oncol. 1997; 66: 179185.
  • 13
    Victor S, Horwitz EM, Kini VR, et al. Impact of clinical, pathologic, and treatment-related factors on outcome in patients with locally advanced breast cancer treated with multimodality therapy. Am J Clin Oncol. 1999; 22: 119125.
  • 14
    Newman LA, Kuerer HM, Hunt KK, et al. Response to induiction chemotherapy in black and white patients with locally advanced breast cancer. Breast J. 2000; 6: 242246.
  • 15
    Brito RA, Valero VV, Buzdar AU, et al. Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience. J Clin Oncol. 2001; 19: 628633.
  • 16
    Fitzgibbons PL, Page DL, Weaver D, et al. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 2000; 124: 966978.
  • 17
    Recht A, Edge SB, Solin LJ, et al. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol. 2001; 19: 15391569.
  • 18
    Donegan WL. Management of early invasive carcinoma (TNM Stages I and II). In: DoneganWL, SprattJS, editors. Cancer of the breast, 5th edition. Philadelphia: Saunders, 2002: 535565.
  • 19
    Clark J, Rosenman J, Cance W, Halle J, Graham M. Extending the indications for breast-conserving treatment to patients with locally advanced breast cancer. Int J Radiat Oncol Biol Phys. 1998; 42: 345350.
  • 20
    Inaji H, Komoike Y, Motomura K, et al. Breast-conserving treatment after neoadjuvant chemotherapy in large breast cancer. Breast Cancer. 2002; 9: 2025.
  • 21
    Cance WG, Carey LA, Calvo BF, et al. Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival. Ann Surg. 2002; 236: 295302.
  • 22
    Morrow M. Physical examination of the breast. In: HarrisJR, LippmanME, MorrowM, OsborneCK, editors. Diseases of the breast, 2nd edition. Philadelphia: Lippincott Williams & Wilkins, 2000: 3336.
  • 23
    Speyer JL, Muggia FM. Management of locally advanced breast cancer. In: RosesDF, editor. Breast cancer. Philadelphia: Churchill Livingstone, 1999: 493502.
  • 24
    Rosen PP. Unusual clinical presentations of carcinoma. In: RosenPP. Rosen's breast pathology, 2nd edition. Philadelphia: Lippincott Williams & Wilkins, 2001: 653687.
  • 25
    Sloane JP. Infiltrating carcinoma—pathological types. In: SloaneJP. Biopsy pathology of the breast ( 2nd edition). London: Arnold, 2001: 170214.
  • 26
    Rosen PP. Staging of breast carcinoma. In: RosenPP. Rosen's breast pathology, 2nd edition. Philadelphia: Lippincott Williams & Wilkins, 2001: 253256.